Repository logo
 

Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.

Published version
Peer-reviewed

Change log

Authors

Greenwood, Edward JD 
Williamson, James C 
Sienkiewicz, Agata 
Naamati, Adi 
Matheson, Nicholas J 

Abstract

HIV-1 encodes four "accessory proteins" (Vif, Vpr, Vpu, and Nef), dispensable for viral replication in vitro but essential for viral pathogenesis in vivo. Well characterized cellular targets have been associated with Vif, Vpu, and Nef, which counteract host restriction and promote viral replication. Conversely, although several substrates of Vpr have been described, their biological significance remains unclear. Here, we use complementary unbiased mass spectrometry-based approaches to demonstrate that Vpr is both necessary and sufficient for the DCAF1/DDB1/CUL4 E3 ubiquitin ligase-mediated degradation of at least 38 cellular proteins, causing systems-level changes to the cellular proteome. We therefore propose that promiscuous targeting of multiple host factors underpins complex Vpr-dependent cellular phenotypes and validate this in the case of G2/M cell cycle arrest. Our model explains how Vpr modulates so many cell biological processes and why the functional consequences of previously described Vpr targets, identified and studied in isolation, have proved elusive.

Description

Keywords

HIV, IP-MS, SIV, TMT, Vpr, Vpx, mass spectrometry, proteomics, pulsed SILAC, Cell Line, Tumor, Conserved Sequence, G2 Phase Cell Cycle Checkpoints, HEK293 Cells, HIV Infections, HIV-1, Humans, Proteolysis, Proteome, Ubiquitin-Protein Ligases, Ubiquitination, vpr Gene Products, Human Immunodeficiency Virus

Journal Title

Cell Rep

Conference Name

Journal ISSN

2211-1247
2211-1247

Volume Title

27

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (210688/Z/18/Z)
Medical Research Council (MR/P008801/1)
NHS Blood and Transplant (NHSBT) (WP15-02)
Wellcome Trust (204845/Z/16/Z)
Wellcome Trust (204845/Z/16/Z)
This work was supported by the Wellcome Trust (PRF 210688/Z/18/Z to PJL), the MRC (CSF MR/P008801/1 to NJM), NHSBT (WPA15-02 to NJM), the NIHR Cambridge BRC, and a Wellcome Trust Strategic Award to the CIMR.
Relationships
Is derived from: